PAIN TRIGGERS
Building tolerance to stimulants and needing higher doses or facing loss of effectiveness
Tolerance breaks severely impair daily functioning and work
Switching medications or dealing with generic quality issues after tolerance
SaaS· ADHD adults on Adderall IRPain 8.00/10WTP 7.0/10Market 8.0/10Validation 9.0Confidence 75%May 9, 2026
SustainStim: Tolerance Delay Protocol for Long-term Adderall Users
Rapid tolerance buildup to stimulants like Adderall forces dose increases or complete loss of effectiveness, while tolerance breaks destroy work/productivity and med switches are unreliable with variable generics.
adhdchronic-conditionhabit-buildinghealthcaremental-healthmobile-appproductivitysaassupplement-trackingwellness
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
ADHD patients on stimulants like Adderall experience tolerance buildup requiring dose increases, with fears of eventually maxing out and losing effectiveness, plus disruptions from breaks or med switches.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Concern about med tolerance
ADHD16
my medication was working great until February... It does nothing anymore
commentFor me personally, I have been on IR since 2023. I started out on 10mg and have worked my way up to 30mg in the morning and 20mg in the afternoon since August of last year. I am at a loss right now with no idea what to do because my medication was working great until February of this year. Since then I am not sure it is as much as my dosage isn't working for me, but the quality of the generics I am receiving. It does nothing to help my symptoms anymore, I feel like I have been on a rollercoaster of emotional, mental and spiritual chaos since then. My doctor tried me on Vyvanse and it caused me severe depression and I was eating everything in sight. Now I am back to bogus generics (Epic/Elite/Sandoz). It feels hopeless because none of these feel right
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
ADHD adults on Adderall IRLong Term A D H D Stimulant Users
Working adults with ADHD who rely on Adderall IR/XR daily for focus and functioning but experience tolerance after months and fear maxing out their dose.
Context
Maintain consistent long-term effectiveness of current stimulant medication (e.g. Adderall) for daily functioning without tolerance issues or major side effects from alternatives/breaks.
Taking half dose on weekends instead of full breaks
Planning tolerance breaks only during vacations or low-need periods
Current Workarounds
Taking half doses on weekends to slow tolerance
Scheduling full breaks only during vacations
Continuing to increase dose despite long-term worries
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Psychiatrist advice to simply switch meds when maxed out, which may not work as well
Tolerance breaks cause significant functional impairment and recovery time
Generic stimulant quality variability leading to sudden loss of effectiveness
OPPORTUNITY & VALUE
Why Now
Multiple users report tolerance after months, fear of maxing out, and major disruption from breaks or switches.
Value Proposition
Focused exclusively on extending current stimulant effectiveness rather than med switching or full digital therapeutics.
Product Direction
A 4-week rolling protocol app combining evidence-based lifestyle timing, micro-habit tracking, and adjunct supplement guidance to slow tolerance while staying on current prescription without forced breaks or switches.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$19/moIndividual user plan
Model
SaaS subscription
WILLINGNESS TO PAY
Users already pay for meds and fear losing functionality entirely; signals show strong aversion to breaks that impair work and willingness to try anything that delays tolerance without switching.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Stay effective on your current Adderall dose for 6+ months without breaks.”
A 4-week rolling protocol app combining evidence-based lifestyle timing, micro-habit tracking, and adjunct supplement guidance to slow tolerance while staying on current prescription without forced breaks or switches.
Core Features
Daily effectiveness journal with symptom scoring
Personalized timing + nutrition protocol calendar
Adjunct supplement tracker (magnesium, L-tyrosine etc)
Tolerance trend dashboard and alerts
Weekly Roadmap
1
W1-W2
Core tracking and basic protocol engine built for single user.
- •Build symptom + effectiveness daily journal
- •Create baseline tolerance scoring algorithm
- •Implement simple calendar for timing protocols
2
W3-W4
Supplement tracker and trend dashboard functional.
- •Add supplement logging and reminders
- •Build tolerance trend visualization
- •Create 28-day rolling protocol templates
3
W5
Internal testing with 8 beta users and polish.
- •Recruit beta users from r/ADHD
- •Iterate based on feedback
- •Add disclaimer flows and export reports
4
W6
Public beta launch with first 50 subscribers.
- •Stripe integration for subscriptions
- •Launch post in key ADHD subreddits
- •Set up basic onboarding email sequence
Launch Strategy
Reddit ADHD communities (r/ADHD, r/adderall), targeted Facebook groups, and TikTok ADHD creator partnerships
RISKS & ASSUMPTIONS
Top Risks
Medical advice liability
Users may misinterpret app as replacement for doctor guidance; must include strong disclaimers.
Variable individual response
Protocol may work well for some but not others, leading to refunds and poor reviews.
Adherence to daily protocol
ADHD users struggle with new habits; high churn if tracking feels burdensome.
Supplement efficacy evidence
Limited clinical data on adjuncts for stimulant tolerance.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "chronic-condition", "habit-building", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "SustainStim: Tolerance Delay Protocol for Long-term Adderall Users" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.